Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H55N5O18 |
Molecular Weight | 761.7697 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 23 / 23 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]4(O[C@@H]1[C@@H](CO)O[C@@H](O[C@]2([H])[C@@H](O)[C@H](N)C[C@H](N)[C@@]2([H])O[C@H]3O[C@H](CO)[C@@H](O)C[C@H]3N)[C@@H]1O)O[C@@H](CN)[C@@]([H])(O[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]5O)[C@H](O)[C@H]4N
InChI
InChIKey=DBLVDAUGBTYDFR-SWMBIRFSSA-N
InChI=1S/C29H55N5O18/c30-3-11-23(51-28-20(43)19(42)17(40)13(5-36)47-28)18(41)15(34)27(45-11)50-24-14(6-37)48-29(21(24)44)52-25-16(39)7(31)1-8(32)22(25)49-26-9(33)2-10(38)12(4-35)46-26/h7-29,35-44H,1-6,30-34H2/t7-,8+,9-,10+,11+,12-,13-,14-,15-,16+,17-,18-,19+,20+,21-,22-,23-,24-,25-,26-,27-,28-,29+/m1/s1
Lividomycin is the antibacterial agent produced by Streptomyces lividus. It is aminoglycoside antibiotic. Lividomycin binds to bacterial ribosomes and inhibits protein synthesis. In vitro development of resistance to lividomycin in P. aeruginosa and M. tuberculosis was much slower than that to kanamycin, but was comparable in Staphylococcus aureus. Lividomycin showed a positive protecting effect for the experimental infections in mice with several bacteria such as S. aureus, P. aeruginosa, Klebsiella pneumoniae and Escherichia coli. It was fairly effective for the experimental infection with the kanamycin-resistant strains of E. coli and P. aeruginosa producing the kanamycin-phosphorylating enzyme.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[The experimental studies on antituberculous activity of lividomycin]. | 1972 May |
|
In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. | 1981 Sep-Oct |
|
Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. | 1993 Sep 24 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
A606AJ494W
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
36441-41-5
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
DTXSID8023218
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
DB04728
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
72394
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
C174602
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
100000082546
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
71960
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
Lividomycin
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
3575
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
C100306
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
71961
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
SUB08538MIG
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
1589
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY | |||
|
CHEMBL389029
Created by
admin on Sat Dec 16 16:33:15 GMT 2023 , Edited by admin on Sat Dec 16 16:33:15 GMT 2023
|
PRIMARY |
ACTIVE MOIETY